Nurix Therapeutics (NRIX) Capital Expenditures (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Capital Expenditures of $1.39 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), down 48.7% from $2.71 million a year earlier and down 28.1% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Capital Expenditures (2019 - 2026) Analysis & Trends
On a TTM basis, Nurix Therapeutics' Capital Expenditures came in at $9.5 million as of Aug 31, 2026, down 13.4% year-over-year; for FY2025 (ended Nov 30, 2025), it was $14 million, up 51.0% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- Across earlier fiscal years, Capital Expenditures came in at $9.27 million in FY2024 (+10.4%), $8.4 million in FY2023 (-31.4%), $12.24 million in FY2022 (+116.3%) and $5.66 million in FY2021 (+24.3%).
- Quarterly Capital Expenditures has ranged from $862,000 in fiscal Q4 2021 to $5.13 million in fiscal Q4 2025 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with growth averaging 6.7% over the last eight quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 311.9% in fiscal Q1 2022, against a decline of 70.0% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.94 million (Q2 2026), $1.05 million (Q1 2026) and $5.13 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Nurix Therapeutics | 2.84 Bn | 215.50 Mn | - | 1.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 1.39 Mn |
| May 31, 2026 | 1.94 Mn |
| Feb 28, 2026 | 1.05 Mn |
| Nov 30, 2025 | 5.13 Mn |
| Aug 31, 2025 | 2.71 Mn |
| May 31, 2025 | 2.68 Mn |
| Feb 28, 2025 | 3.49 Mn |
| Nov 30, 2024 | 2.11 Mn |
| Aug 31, 2024 | 2.35 Mn |
| May 31, 2024 | 1.94 Mn |
| Feb 29, 2024 | 2.88 Mn |
| Nov 30, 2023 | 2.59 Mn |
| Aug 31, 2023 | 2.46 Mn |
| May 31, 2023 | 1.08 Mn |
| Feb 28, 2023 | 2.28 Mn |
| Nov 30, 2022 | 2.57 Mn |
| Aug 31, 2022 | 3.42 Mn |
| May 31, 2022 | 2.79 Mn |
| Feb 28, 2022 | 3.47 Mn |
| Nov 30, 2021 | 862,000.00 |
API Access
Nurix Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();